ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biosimulation Software Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-30R18257
Home | Market Reports | Computers & Electronics| Software
Global Biosimulation Software Market Research Report 2024
BUY CHAPTERS

Global Biosimulation Software Market Research Report 2026

Code: QYRE-Auto-30R18257
Report
2026-01-23
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Certara
Dassault Systèmes
Schrödinger
Chemical Computing
Rosa & Co
Genedata Ag
Physiomics PLC
In Silico Biosciences
Allucent
Cellworks Group
VeriSIM Life
Charnwood Discovery
The MathWorks
ANSYS
Instem Group of Companies
InSilico Medicine
SCM
BioSymetrics
Atomwise
Insitro
Clinithink
Simulations
Advanced Chemistry
OpenEye (Cadence)
Netabolics SRL
Rosa & Co

Biosimulation Software Market

The global Biosimulation Software market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Biosimulation software is a type of computational tool used to model and simulate biological processes and systems. These programs enable researchers and scientists to predict the behavior of biological entities, such as cells, tissues, and entire organisms, under various conditions. By using mathematical models and algorithms, biosimulation software can help in understanding complex biological interactions, drug interactions, metabolic pathways, and disease progression.
The North American market for Biosimulation Software is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Biosimulation Software is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Biosimulation Software in Pharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Biosimulation Software include Certara, Simulations, Dassault Systèmes, Schrödinger, Advanced Chemistry, Chemical Computing, Rosa & Co., Genedata, Physiomics, In Silico Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Biosimulation Software market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biosimulation Software. The Biosimulation Software market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Biosimulation Software market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Biosimulation Software manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Biosimulation Software Market Report

Report Metric Details
Report Name Biosimulation Software Market
Segment by Type
  • Independent Modules
  • Integrated Software Platform
Segment by Application
  • Pharmaceuticals
  • Medical Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Certara, Simulations, Dassault Systèmes, Schrödinger, Advanced Chemistry, Chemical Computing, Rosa & Co., Genedata, Physiomics, In Silico Biosciences, Allucent, OpenEye (Cadence), Cellworks Group, VeriSIM Life, Netabolics SRL, Charnwood Discovery, The MathWorks, ANSYS, Instem Group of Companies, Insilico Medicine, SCM, BioSymetrics, Atomwise, insitro, Clinithink
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Biosimulation Software companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Biosimulation Software Market report?

Ans: The main players in the Biosimulation Software Market are Certara, Simulations, Dassault Systèmes, Schrödinger, Advanced Chemistry, Chemical Computing, Rosa & Co., Genedata, Physiomics, In Silico Biosciences, Allucent, OpenEye (Cadence), Cellworks Group, VeriSIM Life, Netabolics SRL, Charnwood Discovery, The MathWorks, ANSYS, Instem Group of Companies, Insilico Medicine, SCM, BioSymetrics, Atomwise, insitro, Clinithink

What are the Application segmentation covered in the Biosimulation Software Market report?

Ans: The Applications covered in the Biosimulation Software Market report are Pharmaceuticals, Medical Research, Others

What are the Type segmentation covered in the Biosimulation Software Market report?

Ans: The Types covered in the Biosimulation Software Market report are Independent Modules, Integrated Software Platform

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimulation Software Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Independent Modules
1.2.3 Integrated Software Platform
1.3 Market by Application
1.3.1 Global Biosimulation Software Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceuticals
1.3.3 Medical Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimulation Software Market Perspective (2021–2032)
2.2 Global Biosimulation Software Growth Trends by Region
2.2.1 Global Biosimulation Software Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Biosimulation Software Historic Market Size by Region (2021–2026)
2.2.3 Biosimulation Software Forecasted Market Size by Region (2027–2032)
2.3 Biosimulation Software Market Dynamics
2.3.1 Biosimulation Software Industry Trends
2.3.2 Biosimulation Software Market Drivers
2.3.3 Biosimulation Software Market Challenges
2.3.4 Biosimulation Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimulation Software Players by Revenue
3.1.1 Global Top Biosimulation Software Players by Revenue (2021–2026)
3.1.2 Global Biosimulation Software Revenue Market Share by Players (2021–2026)
3.2 Global Top Biosimulation Software Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Biosimulation Software Revenue
3.4 Global Biosimulation Software Market Concentration Ratio
3.4.1 Global Biosimulation Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimulation Software Revenue in 2025
3.5 Global Key Players of Biosimulation Software Head Offices and Areas Served
3.6 Global Key Players of Biosimulation Software, Products and Applications
3.7 Global Key Players of Biosimulation Software, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Biosimulation Software Breakdown Data by Type
4.1 Global Biosimulation Software Historic Market Size by Type (2021–2026)
4.2 Global Biosimulation Software Forecasted Market Size by Type (2027–2032)
5 Biosimulation Software Breakdown Data by Application
5.1 Global Biosimulation Software Historic Market Size by Application (2021–2026)
5.2 Global Biosimulation Software Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Biosimulation Software Market Size (2021–2032)
6.2 North America Biosimulation Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Biosimulation Software Market Size by Country (2021–2026)
6.4 North America Biosimulation Software Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimulation Software Market Size (2021–2032)
7.2 Europe Biosimulation Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Biosimulation Software Market Size by Country (2021–2026)
7.4 Europe Biosimulation Software Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Biosimulation Software Market Size (2021–2032)
8.2 Asia-Pacific Biosimulation Software Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Biosimulation Software Market Size by Region (2021–2026)
8.4 Asia-Pacific Biosimulation Software Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Biosimulation Software Market Size (2021–2032)
9.2 Latin America Biosimulation Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Biosimulation Software Market Size by Country (2021–2026)
9.4 Latin America Biosimulation Software Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimulation Software Market Size (2021–2032)
10.2 Middle East & Africa Biosimulation Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Biosimulation Software Market Size by Country (2021–2026)
10.4 Middle East & Africa Biosimulation Software Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Certara
11.1.1 Certara Company Details
11.1.2 Certara Business Overview
11.1.3 Certara Biosimulation Software Introduction
11.1.4 Certara Revenue in Biosimulation Software Business (2021–2026)
11.1.5 Certara Recent Development
11.2 Simulations
11.2.1 Simulations Company Details
11.2.2 Simulations Business Overview
11.2.3 Simulations Biosimulation Software Introduction
11.2.4 Simulations Revenue in Biosimulation Software Business (2021–2026)
11.2.5 Simulations Recent Development
11.3 Dassault Systèmes
11.3.1 Dassault Systèmes Company Details
11.3.2 Dassault Systèmes Business Overview
11.3.3 Dassault Systèmes Biosimulation Software Introduction
11.3.4 Dassault Systèmes Revenue in Biosimulation Software Business (2021–2026)
11.3.5 Dassault Systèmes Recent Development
11.4 Schrödinger
11.4.1 Schrödinger Company Details
11.4.2 Schrödinger Business Overview
11.4.3 Schrödinger Biosimulation Software Introduction
11.4.4 Schrödinger Revenue in Biosimulation Software Business (2021–2026)
11.4.5 Schrödinger Recent Development
11.5 Advanced Chemistry
11.5.1 Advanced Chemistry Company Details
11.5.2 Advanced Chemistry Business Overview
11.5.3 Advanced Chemistry Biosimulation Software Introduction
11.5.4 Advanced Chemistry Revenue in Biosimulation Software Business (2021–2026)
11.5.5 Advanced Chemistry Recent Development
11.6 Chemical Computing
11.6.1 Chemical Computing Company Details
11.6.2 Chemical Computing Business Overview
11.6.3 Chemical Computing Biosimulation Software Introduction
11.6.4 Chemical Computing Revenue in Biosimulation Software Business (2021–2026)
11.6.5 Chemical Computing Recent Development
11.7 Rosa & Co.
11.7.1 Rosa & Co. Company Details
11.7.2 Rosa & Co. Business Overview
11.7.3 Rosa & Co. Biosimulation Software Introduction
11.7.4 Rosa & Co. Revenue in Biosimulation Software Business (2021–2026)
11.7.5 Rosa & Co. Recent Development
11.8 Genedata
11.8.1 Genedata Company Details
11.8.2 Genedata Business Overview
11.8.3 Genedata Biosimulation Software Introduction
11.8.4 Genedata Revenue in Biosimulation Software Business (2021–2026)
11.8.5 Genedata Recent Development
11.9 Physiomics
11.9.1 Physiomics Company Details
11.9.2 Physiomics Business Overview
11.9.3 Physiomics Biosimulation Software Introduction
11.9.4 Physiomics Revenue in Biosimulation Software Business (2021–2026)
11.9.5 Physiomics Recent Development
11.10 In Silico Biosciences
11.10.1 In Silico Biosciences Company Details
11.10.2 In Silico Biosciences Business Overview
11.10.3 In Silico Biosciences Biosimulation Software Introduction
11.10.4 In Silico Biosciences Revenue in Biosimulation Software Business (2021–2026)
11.10.5 In Silico Biosciences Recent Development
11.11 Allucent
11.11.1 Allucent Company Details
11.11.2 Allucent Business Overview
11.11.3 Allucent Biosimulation Software Introduction
11.11.4 Allucent Revenue in Biosimulation Software Business (2021–2026)
11.11.5 Allucent Recent Development
11.12 OpenEye (Cadence)
11.12.1 OpenEye (Cadence) Company Details
11.12.2 OpenEye (Cadence) Business Overview
11.12.3 OpenEye (Cadence) Biosimulation Software Introduction
11.12.4 OpenEye (Cadence) Revenue in Biosimulation Software Business (2021–2026)
11.12.5 OpenEye (Cadence) Recent Development
11.13 Cellworks Group
11.13.1 Cellworks Group Company Details
11.13.2 Cellworks Group Business Overview
11.13.3 Cellworks Group Biosimulation Software Introduction
11.13.4 Cellworks Group Revenue in Biosimulation Software Business (2021–2026)
11.13.5 Cellworks Group Recent Development
11.14 VeriSIM Life
11.14.1 VeriSIM Life Company Details
11.14.2 VeriSIM Life Business Overview
11.14.3 VeriSIM Life Biosimulation Software Introduction
11.14.4 VeriSIM Life Revenue in Biosimulation Software Business (2021–2026)
11.14.5 VeriSIM Life Recent Development
11.15 Netabolics SRL
11.15.1 Netabolics SRL Company Details
11.15.2 Netabolics SRL Business Overview
11.15.3 Netabolics SRL Biosimulation Software Introduction
11.15.4 Netabolics SRL Revenue in Biosimulation Software Business (2021–2026)
11.15.5 Netabolics SRL Recent Development
11.16 Charnwood Discovery
11.16.1 Charnwood Discovery Company Details
11.16.2 Charnwood Discovery Business Overview
11.16.3 Charnwood Discovery Biosimulation Software Introduction
11.16.4 Charnwood Discovery Revenue in Biosimulation Software Business (2021–2026)
11.16.5 Charnwood Discovery Recent Development
11.17 The MathWorks
11.17.1 The MathWorks Company Details
11.17.2 The MathWorks Business Overview
11.17.3 The MathWorks Biosimulation Software Introduction
11.17.4 The MathWorks Revenue in Biosimulation Software Business (2021–2026)
11.17.5 The MathWorks Recent Development
11.18 ANSYS
11.18.1 ANSYS Company Details
11.18.2 ANSYS Business Overview
11.18.3 ANSYS Biosimulation Software Introduction
11.18.4 ANSYS Revenue in Biosimulation Software Business (2021–2026)
11.18.5 ANSYS Recent Development
11.19 Instem Group of Companies
11.19.1 Instem Group of Companies Company Details
11.19.2 Instem Group of Companies Business Overview
11.19.3 Instem Group of Companies Biosimulation Software Introduction
11.19.4 Instem Group of Companies Revenue in Biosimulation Software Business (2021–2026)
11.19.5 Instem Group of Companies Recent Development
11.20 Insilico Medicine
11.20.1 Insilico Medicine Company Details
11.20.2 Insilico Medicine Business Overview
11.20.3 Insilico Medicine Biosimulation Software Introduction
11.20.4 Insilico Medicine Revenue in Biosimulation Software Business (2021–2026)
11.20.5 Insilico Medicine Recent Development
11.21 SCM
11.21.1 SCM Company Details
11.21.2 SCM Business Overview
11.21.3 SCM Biosimulation Software Introduction
11.21.4 SCM Revenue in Biosimulation Software Business (2021–2026)
11.21.5 SCM Recent Development
11.22 BioSymetrics
11.22.1 BioSymetrics Company Details
11.22.2 BioSymetrics Business Overview
11.22.3 BioSymetrics Biosimulation Software Introduction
11.22.4 BioSymetrics Revenue in Biosimulation Software Business (2021–2026)
11.22.5 BioSymetrics Recent Development
11.23 Atomwise
11.23.1 Atomwise Company Details
11.23.2 Atomwise Business Overview
11.23.3 Atomwise Biosimulation Software Introduction
11.23.4 Atomwise Revenue in Biosimulation Software Business (2021–2026)
11.23.5 Atomwise Recent Development
11.24 insitro
11.24.1 insitro Company Details
11.24.2 insitro Business Overview
11.24.3 insitro Biosimulation Software Introduction
11.24.4 insitro Revenue in Biosimulation Software Business (2021–2026)
11.24.5 insitro Recent Development
11.25 Clinithink
11.25.1 Clinithink Company Details
11.25.2 Clinithink Business Overview
11.25.3 Clinithink Biosimulation Software Introduction
11.25.4 Clinithink Revenue in Biosimulation Software Business (2021–2026)
11.25.5 Clinithink Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Certara
Dassault Systèmes
Schrödinger
Chemical Computing
Rosa & Co
Genedata Ag
Physiomics PLC
In Silico Biosciences
Allucent
Cellworks Group
VeriSIM Life
Charnwood Discovery
The MathWorks
ANSYS
Instem Group of Companies
InSilico Medicine
SCM
BioSymetrics
Atomwise
Insitro
Clinithink
Simulations
Advanced Chemistry
OpenEye (Cadence)
Netabolics SRL
Rosa & Co
List of Tables
 Table 1. Global Biosimulation Software Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Independent Modules
 Table 3. Key Players of Integrated Software Platform
 Table 4. Global Biosimulation Software Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Biosimulation Software Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Biosimulation Software Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Biosimulation Software Market Share by Region (2021–2026)
 Table 8. Global Biosimulation Software Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Biosimulation Software Market Share by Region (2027–2032)
 Table 10. Biosimulation Software Market Trends
 Table 11. Biosimulation Software Market Drivers
 Table 12. Biosimulation Software Market Challenges
 Table 13. Biosimulation Software Market Restraints
 Table 14. Global Biosimulation Software Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Biosimulation Software Market Share by Players (2021–2026)
 Table 16. Global Top Biosimulation Software Players by Tier (Tier 1, Tier 2, and Tier 3), based on Biosimulation Software Revenue, 2025
 Table 17. Ranking of Global Top Biosimulation Software Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Biosimulation Software Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Biosimulation Software, Headquarters and Area Served
 Table 20. Global Key Players of Biosimulation Software, Products and Applications
 Table 21. Global Key Players of Biosimulation Software, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Biosimulation Software Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Biosimulation Software Revenue Market Share by Type (2021–2026)
 Table 25. Global Biosimulation Software Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Biosimulation Software Revenue Market Share by Type (2027–2032)
 Table 27. Global Biosimulation Software Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Biosimulation Software Revenue Market Share by Application (2021–2026)
 Table 29. Global Biosimulation Software Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Biosimulation Software Revenue Market Share by Application (2027–2032)
 Table 31. North America Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Biosimulation Software Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Biosimulation Software Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Biosimulation Software Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Biosimulation Software Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Biosimulation Software Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Biosimulation Software Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Biosimulation Software Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Biosimulation Software Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Biosimulation Software Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Biosimulation Software Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Biosimulation Software Market Size by Country (US$ Million), 2027–2032
 Table 46. Certara Company Details
 Table 47. Certara Business Overview
 Table 48. Certara Biosimulation Software Product
 Table 49. Certara Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 50. Certara Recent Development
 Table 51. Simulations Company Details
 Table 52. Simulations Business Overview
 Table 53. Simulations Biosimulation Software Product
 Table 54. Simulations Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 55. Simulations Recent Development
 Table 56. Dassault Systèmes Company Details
 Table 57. Dassault Systèmes Business Overview
 Table 58. Dassault Systèmes Biosimulation Software Product
 Table 59. Dassault Systèmes Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 60. Dassault Systèmes Recent Development
 Table 61. Schrödinger Company Details
 Table 62. Schrödinger Business Overview
 Table 63. Schrödinger Biosimulation Software Product
 Table 64. Schrödinger Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 65. Schrödinger Recent Development
 Table 66. Advanced Chemistry Company Details
 Table 67. Advanced Chemistry Business Overview
 Table 68. Advanced Chemistry Biosimulation Software Product
 Table 69. Advanced Chemistry Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 70. Advanced Chemistry Recent Development
 Table 71. Chemical Computing Company Details
 Table 72. Chemical Computing Business Overview
 Table 73. Chemical Computing Biosimulation Software Product
 Table 74. Chemical Computing Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 75. Chemical Computing Recent Development
 Table 76. Rosa & Co. Company Details
 Table 77. Rosa & Co. Business Overview
 Table 78. Rosa & Co. Biosimulation Software Product
 Table 79. Rosa & Co. Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 80. Rosa & Co. Recent Development
 Table 81. Genedata Company Details
 Table 82. Genedata Business Overview
 Table 83. Genedata Biosimulation Software Product
 Table 84. Genedata Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 85. Genedata Recent Development
 Table 86. Physiomics Company Details
 Table 87. Physiomics Business Overview
 Table 88. Physiomics Biosimulation Software Product
 Table 89. Physiomics Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 90. Physiomics Recent Development
 Table 91. In Silico Biosciences Company Details
 Table 92. In Silico Biosciences Business Overview
 Table 93. In Silico Biosciences Biosimulation Software Product
 Table 94. In Silico Biosciences Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 95. In Silico Biosciences Recent Development
 Table 96. Allucent Company Details
 Table 97. Allucent Business Overview
 Table 98. Allucent Biosimulation Software Product
 Table 99. Allucent Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 100. Allucent Recent Development
 Table 101. OpenEye (Cadence) Company Details
 Table 102. OpenEye (Cadence) Business Overview
 Table 103. OpenEye (Cadence) Biosimulation Software Product
 Table 104. OpenEye (Cadence) Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 105. OpenEye (Cadence) Recent Development
 Table 106. Cellworks Group Company Details
 Table 107. Cellworks Group Business Overview
 Table 108. Cellworks Group Biosimulation Software Product
 Table 109. Cellworks Group Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 110. Cellworks Group Recent Development
 Table 111. VeriSIM Life Company Details
 Table 112. VeriSIM Life Business Overview
 Table 113. VeriSIM Life Biosimulation Software Product
 Table 114. VeriSIM Life Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 115. VeriSIM Life Recent Development
 Table 116. Netabolics SRL Company Details
 Table 117. Netabolics SRL Business Overview
 Table 118. Netabolics SRL Biosimulation Software Product
 Table 119. Netabolics SRL Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 120. Netabolics SRL Recent Development
 Table 121. Charnwood Discovery Company Details
 Table 122. Charnwood Discovery Business Overview
 Table 123. Charnwood Discovery Biosimulation Software Product
 Table 124. Charnwood Discovery Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 125. Charnwood Discovery Recent Development
 Table 126. The MathWorks Company Details
 Table 127. The MathWorks Business Overview
 Table 128. The MathWorks Biosimulation Software Product
 Table 129. The MathWorks Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 130. The MathWorks Recent Development
 Table 131. ANSYS Company Details
 Table 132. ANSYS Business Overview
 Table 133. ANSYS Biosimulation Software Product
 Table 134. ANSYS Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 135. ANSYS Recent Development
 Table 136. Instem Group of Companies Company Details
 Table 137. Instem Group of Companies Business Overview
 Table 138. Instem Group of Companies Biosimulation Software Product
 Table 139. Instem Group of Companies Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 140. Instem Group of Companies Recent Development
 Table 141. Insilico Medicine Company Details
 Table 142. Insilico Medicine Business Overview
 Table 143. Insilico Medicine Biosimulation Software Product
 Table 144. Insilico Medicine Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 145. Insilico Medicine Recent Development
 Table 146. SCM Company Details
 Table 147. SCM Business Overview
 Table 148. SCM Biosimulation Software Product
 Table 149. SCM Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 150. SCM Recent Development
 Table 151. BioSymetrics Company Details
 Table 152. BioSymetrics Business Overview
 Table 153. BioSymetrics Biosimulation Software Product
 Table 154. BioSymetrics Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 155. BioSymetrics Recent Development
 Table 156. Atomwise Company Details
 Table 157. Atomwise Business Overview
 Table 158. Atomwise Biosimulation Software Product
 Table 159. Atomwise Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 160. Atomwise Recent Development
 Table 161. insitro Company Details
 Table 162. insitro Business Overview
 Table 163. insitro Biosimulation Software Product
 Table 164. insitro Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 165. insitro Recent Development
 Table 166. Clinithink Company Details
 Table 167. Clinithink Business Overview
 Table 168. Clinithink Biosimulation Software Product
 Table 169. Clinithink Revenue in Biosimulation Software Business (US$ Million), 2021–2026
 Table 170. Clinithink Recent Development
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. Authors List of This Report


List of Figures
 Figure 1. Biosimulation Software Picture
 Figure 2. Global Biosimulation Software Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Biosimulation Software Market Share by Type: 2025 vs 2032
 Figure 4. Independent Modules Features
 Figure 5. Integrated Software Platform Features
 Figure 6. Global Biosimulation Software Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Biosimulation Software Market Share by Application: 2025 vs 2032
 Figure 8. Pharmaceuticals Case Studies
 Figure 9. Medical Research Case Studies
 Figure 10. Others Case Studies
 Figure 11. Biosimulation Software Report Years Considered
 Figure 12. Global Biosimulation Software Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Biosimulation Software Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Biosimulation Software Market Share by Region: 2025 vs 2032
 Figure 15. Global Biosimulation Software Market Share by Players in 2025
 Figure 16. Global Biosimulation Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Biosimulation Software Revenue in 2025
 Figure 18. North America Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Biosimulation Software Market Share by Country (2021–2032)
 Figure 20. United States Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Biosimulation Software Market Share by Country (2021–2032)
 Figure 24. Germany Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Biosimulation Software Market Share by Region (2021–2032)
 Figure 32. China Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Biosimulation Software Market Share by Country (2021–2032)
 Figure 40. Mexico Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Biosimulation Software Market Share by Country (2021–2032)
 Figure 44. Israel Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Biosimulation Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Certara Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 48. Simulations Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 49. Dassault Systèmes Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 50. Schrödinger Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 51. Advanced Chemistry Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 52. Chemical Computing Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 53. Rosa & Co. Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 54. Genedata Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 55. Physiomics Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 56. In Silico Biosciences Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 57. Allucent Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 58. OpenEye (Cadence) Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 59. Cellworks Group Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 60. VeriSIM Life Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 61. Netabolics SRL Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 62. Charnwood Discovery Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 63. The MathWorks Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 64. ANSYS Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 65. Instem Group of Companies Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 66. Insilico Medicine Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 67. SCM Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 68. BioSymetrics Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 69. Atomwise Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 70. insitro Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 71. Clinithink Revenue Growth Rate in Biosimulation Software Business (2021–2026)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Biosimulation Analysis Software Market Research Report 2024
Global Biostatistics Software Market Research Report 2024
Global Bioprocess Automation Software Market Research Report 2025
Global Bioprocess Control Software Market Research Report 2025
Global Healthcare Simulation Software Market Research Report 2024
Global Biostimulators Injection Services Market Research Report 2025
Global 3D Bioprinting Software Market Research Report 2024
Global Biological Image Analysis Software Market Research Report 2024
Global Human Biomechanics Analysis Software Market Research Report 2024
Global Simulation and Testing Software Market Research Report 2024
Biological Cell Analysis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bioreactor System Market Research Report 2024
Global Biomechanical Acquisition and Analysis Software Market Research Report 2024
Global Bioelectrical Stimulation Device Market Research Report 2024
Global Micro Organism Plant Biostimulators Market Research Report 2025
Bio Simulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Surgery Simulation Software Market Research Report 2025
Global Biological Amplifier Market Research Report 2024
Global Solid Biostimulant Market Research Report 2025
Global Pregnancy Recording Software Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions